Zacks.com releases the latest list of Zacks Rank Buy Stocks. Every day on Zacks.com, four stock picks are made based on criteria for the each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today are Kirby Corporation (NYSE: KEX), Chicago Bridge & Iron Company N.V. (NYSE: CBI), Haemonetics Corporation (NYSE: HAE) and Companhia Paranaense de Energia - COPEL (NYSE: ELP).
Stocks ranked #1 (Strong Buy) by Zacks have produced an average annual return of +32.2% since inception in 1988. During the 2000-2002 bear market, Zacks #1 Rank stocks gained 43.8% while the S&P 500 tumbled -37.6%. To see the full Zacks #1 Rank (Strong Buy) List, or the rank for any other stock, visit: http://at.zacks.com/?id=88
Here is a synopsis of today’s Zacks Rank Buy Stocks:
Aggressive Growth – Kirby Corporation (NYSE: KEX)
Kirby keeps rolling along. The company has posted an average surprise of 4.3% over the past four quarters. Five of the nine covering analysts for this year have raised their estimates over the past month. Those estimates have risen 11 cents to $2.75 per share. The stock is valued reasonably with a PEG ratio of 1.3.
Zacks Guide to Aggressive Growth Investing (free!): http://at.zacks.com/?id=4309
Growth & Income – Chicago Bridge & Iron Company N.V. (NYSE: CBI)
Chicago Bridge & Iron Company N.V. posted full-year 2007 results in late February, showing growth in many areas, which included 2007 earnings per share of $1.71 versus the year 2006 result of $1.19. Investors who want income combined with growth should consider this company as growth is not the only story here. Chicago Bridge & Iron declared an interim dividend of four cents per share, which was paid out on March 31, 2008. The company’s dividend yield of 0.4% is higher than the industry average. The ROE for CBI is 26%, which is double the industry’s average of 13%.
Zacks Guide to Growth & Income Investing (free!): http://at.zacks.com/?id=4310
Momentum – Haemonetics Corporation (NYSE: HAE)
Haemonetics Corporation's share price has been locked into a very smooth up trend for the last two months after the company reported solid third quarter results on Jan 31 in which revenue was up sharply from the same period last year. The company is also engaged in a number of initiatives to drive its growth trajectory, including restructuring activities in the European zone and the acquisition of third party products. Shares just closed above a key level at $60, and look well positioned to continue the trend.
Zacks Guide to Momentum Investing (free!): http://at.zacks.com/?id=4311
Value – Companhia Paranaense de Energia - COPEL (NYSE: ELP)
Companhia Paranaense de Energia- COPEL is riding the wave of Brazil's economic success in agribusiness as it sees power consumption continuing to rise in the industrial and commercial segments. ELP is an attractive value pick, with a 2008 P/E of 8.68.
Zacks Guide to Value Investing (free!): http://at.zacks.com/?id=4312
The free special report, “Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions,” provides an insightful background about this wealth-building tool. Download your free copy of the report now to prosper in the years to come by visiting http://at.zacks.com/?id=93.
About the Zacks Rank
Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank stocks have generated an average annual return of +32.2%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by 129% annually (+5.3% vs. +12.1%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks “Profit from the Pros” e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=90.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros http://at.zacks.com/?id=91
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contacts:
Aggressive Growth Stocks:
Roopak Chakravarty
312-265-9188
or
Growth
& Income Stocks:
Alex Kolb
312-265-9149
or
Momentum
Stocks:
Michael Vodicka
312-265-9226
or
Value Stocks:
Tracey
Ryniec
312-265-9232
pr@zacks.com
www.zacks.com
